 |
 |
|
|
|
|
 Dear Investors,
D. Western Therapeutics Institute, Inc. (DWTI) has been listed to JASDAQ Stock Exchange NEO on October 23, 2009.
It takes many years, massive amount of funding, and knowledge and expertise of many scientists to identify a innovative drug candidate and finally deliver to a patient as a new drug.
Our business field is to create a new drug candidate, in this long and difficult process of drug research and development.
We have already discovered three innovative drug candidates which are under evaluation in clinical trials; anti-platelet, anti-glaucoma, anti-cancer, and licensed out them to pharmaceuticals.
In addition, we have several on-going discovery projects in the field of ophthalmology, cardiovascular, oncology, and so on.
By fully-utilizing our robust science, expertise and technology, we continue our research for the purpose of creating innovative drugs.
We will ensure stable revenue base and improve balance sheet by continuing a creation of drug candidates, which enhance our corporate value.
In the middle and long term, we are aiming to contribute to society by creating and innovative drug of Japanese origin.
Thank you for your continued warm support.
Sincerely,
|
President and CEO
Yuuichi Hidaka |
 |
|
|
|
| | | | |
| |
|
 |
